Anne Marije van Harten

Investment Director at Apollo Health Ventures

Speaker

Anne Marije van Harten, PhD, is an Investment Director at Apollo Health Ventures, a transatlantic firm that builds and backs companies targeting the biology of aging and age-related disease. She leads investments and company-creation efforts, and serves on the boards of Booster Therapeutics, Refoxy Pharma, and Scripta Therapeutics. She began her investment career at Forbion.

A molecular cell biologist by training, Anne holds a PhD from VU University Amsterdam and held research roles at Thomas Jefferson University and the University of Pennsylvania. She brings a scientist's lens to investing, evaluating founders and therapeutic pipelines from the underlying mechanism to the path to patients.

Apollo Health Ventures pairs active venture creation with early-stage investment in first-in-class assets, with a portfolio that also includes Aeovian Pharmaceuticals, HAYA Therapeutics, and Therini Bio.